Cargando…

Analysis of cancer metabolism with high-throughput technologies

BACKGROUND: Recent advances in genomics and proteomics have allowed us to study the nuances of the Warburg effect – a long-standing puzzle in cancer energy metabolism – at an unprecedented level of detail. While modern next-generation sequencing technologies are extremely powerful, the lack of appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Markovets, Aleksandra A, Herman, Damir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236851/
https://www.ncbi.nlm.nih.gov/pubmed/22166000
http://dx.doi.org/10.1186/1471-2105-12-S10-S8
_version_ 1782218796386222080
author Markovets, Aleksandra A
Herman, Damir
author_facet Markovets, Aleksandra A
Herman, Damir
author_sort Markovets, Aleksandra A
collection PubMed
description BACKGROUND: Recent advances in genomics and proteomics have allowed us to study the nuances of the Warburg effect – a long-standing puzzle in cancer energy metabolism – at an unprecedented level of detail. While modern next-generation sequencing technologies are extremely powerful, the lack of appropriate data analysis tools makes this study difficult. To meet this challenge, we developed a novel application for comparative analysis of gene expression and visualization of RNA-Seq data. RESULTS: We analyzed two biological samples (normal human brain tissue and human cancer cell lines) with high-energy, metabolic requirements. We calculated digital topology and the copy number of every expressed transcript. We observed subtle but remarkable qualitative and quantitative differences between the citric acid (TCA) cycle and glycolysis pathways. We found that in the first three steps of the TCA cycle, digital expression of aconitase 2 (ACO2) in the brain exceeded both citrate synthase (CS) and isocitrate dehydrogenase 2 (IDH2), while in cancer cells this trend was quite the opposite. In the glycolysis pathway, all genes showed higher expression levels in cancer cell lines; and most notably, digital gene expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and enolase (ENO) were considerably increased when compared to the brain sample. CONCLUSIONS: The variations we observed should affect the rates and quantities of ATP production. We expect that the developed tool will provide insights into the subtleties related to the causality between the Warburg effect and neoplastic transformation. Even though we focused on well-known and extensively studied metabolic pathways, the data analysis and visualization pipeline that we developed is particularly valuable as it is global and pathway-independent.
format Online
Article
Text
id pubmed-3236851
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32368512011-12-14 Analysis of cancer metabolism with high-throughput technologies Markovets, Aleksandra A Herman, Damir BMC Bioinformatics Proceedings BACKGROUND: Recent advances in genomics and proteomics have allowed us to study the nuances of the Warburg effect – a long-standing puzzle in cancer energy metabolism – at an unprecedented level of detail. While modern next-generation sequencing technologies are extremely powerful, the lack of appropriate data analysis tools makes this study difficult. To meet this challenge, we developed a novel application for comparative analysis of gene expression and visualization of RNA-Seq data. RESULTS: We analyzed two biological samples (normal human brain tissue and human cancer cell lines) with high-energy, metabolic requirements. We calculated digital topology and the copy number of every expressed transcript. We observed subtle but remarkable qualitative and quantitative differences between the citric acid (TCA) cycle and glycolysis pathways. We found that in the first three steps of the TCA cycle, digital expression of aconitase 2 (ACO2) in the brain exceeded both citrate synthase (CS) and isocitrate dehydrogenase 2 (IDH2), while in cancer cells this trend was quite the opposite. In the glycolysis pathway, all genes showed higher expression levels in cancer cell lines; and most notably, digital gene expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and enolase (ENO) were considerably increased when compared to the brain sample. CONCLUSIONS: The variations we observed should affect the rates and quantities of ATP production. We expect that the developed tool will provide insights into the subtleties related to the causality between the Warburg effect and neoplastic transformation. Even though we focused on well-known and extensively studied metabolic pathways, the data analysis and visualization pipeline that we developed is particularly valuable as it is global and pathway-independent. BioMed Central 2011-10-18 /pmc/articles/PMC3236851/ /pubmed/22166000 http://dx.doi.org/10.1186/1471-2105-12-S10-S8 Text en Copyright ©2011 Markovets and Herman; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Proceedings
Markovets, Aleksandra A
Herman, Damir
Analysis of cancer metabolism with high-throughput technologies
title Analysis of cancer metabolism with high-throughput technologies
title_full Analysis of cancer metabolism with high-throughput technologies
title_fullStr Analysis of cancer metabolism with high-throughput technologies
title_full_unstemmed Analysis of cancer metabolism with high-throughput technologies
title_short Analysis of cancer metabolism with high-throughput technologies
title_sort analysis of cancer metabolism with high-throughput technologies
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236851/
https://www.ncbi.nlm.nih.gov/pubmed/22166000
http://dx.doi.org/10.1186/1471-2105-12-S10-S8
work_keys_str_mv AT markovetsaleksandraa analysisofcancermetabolismwithhighthroughputtechnologies
AT hermandamir analysisofcancermetabolismwithhighthroughputtechnologies